Home > Notice-board > Official notices >
Alterations to the Byelaws: Statutory fees

Search

The Pharmaceutical Journal
Vol 271 No 7262 p222
16 August 2003


Alterations to the Byelaws: Statutory fees

Notice is hereby given in accordance with Section XXVIII of the Byelaws that the Council of the Society has approved proposals to alter the Byelaws concerning fees as hereunder and that it intends to make such alterations after the expiry of 60 days from the date of this notice, subject to such amendments as the Lords of the Privy Council may require.

Section II
Paragraphs 2, 2(ii), 2(iv)(b) substitute £205* for £195
Paragraph 2(iii) substitute £116* for £110 and £89* for £85
Paragraph 2(iv) substitute £22* for £21
Paragraph 2(iv)(a) substitute £94* for £89
Paragraph 2(iv)(b) substitute £89* for £85 and £205* for £195
Paragraph 2(v) substitute £100* for £94
Paragraph 7 substitute £395* for £372

Section XIX
Paragraphs 2(b), 4(d), 5(b), 6(e)(iii) substitute £110* for £81
Paragraph 6(e)(i) substitute £445* for £210
Paragraph 6(e)(i) and (ii) substitute £445* for £429

Section XX
Paragraph 3 substitute £97* for £81
Paragraph 21(b) substitute £112* for £100
Paragraph 26 substitute £135* for £125 and £265* for £250
Paragraph 27 substitute £135* for £125 and £265* for £250

(*or such other amount as the Privy Council may approve)

ANN LEWIS
Secretary and Registrar

Notes:

(1) The fees have been increased by about 5 per cent and an additional percentage has been added to registration, reciprocity and preregistration fees to recover administration costs.

(2) Premises fees are fixed by regulation of the Secretary of State for the Department of Health, to whom the Council will make application for the registration fee to be increased from £155 to £163, the retention fee to be increased from £101 to £125 and the restoration fee to be increased from £320 to £336 as from January 1 2004.

(3) An explanation of the proposed increases appears on Friday

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal